Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Stock markets open on a solid note
Wed, 21 Dec 09:30 am

All major Asian stock markets have opened the day on a solid note with stock markets in Taiwan (up 4.2%), South Korea (up 2.9%), Singapore (1.5%) and Hong Kong (up 1.5%) leading the gains. The Indian stock markets have also opened the day on a firm note. Stocks in the metal and banking space are the biggest gainers.

The BSE-Sensex is trading higher by 270 points (1.8%), while the NSE-Nifty is up by around 81 points (1.8%). Mid cap and small cap stocks are trading in the green as well, with the BSE Mid Cap and BSE Small Cap indices up by 1.5% and 1.1% respectively. The rupee is trading at 52.69 to the US dollar.

Auto stocks have opened the day on a strong note with Tata Motors, Ashok Leyland and Maruti Suzuki leading the gains. However, Hero MotoCorp is facing selling pressure. Auto maker Ashok Leyland has announced that it has acquired an additional 49.1% stake in British bus maker Optare Plc for over Rs 300 m. Owing to refinancing agreement announced yesterday, Ashok Leyland and its associate companies will hike their stake in the British company to 75.1%. The company's share will reach 75.1% of Optare's share capital through placing of shares and raising new equity. The Hinduja Group flagship company had first acquired a 26% stake in Optare in July 2010 as a long term strategic partnership. It considers this as an important move in achieving its vision of being among the top five bus makers globally

Pharma stocks have opened the day in the firm note with Pfizer, Novartis and Abbott India trading in the green. The rural markets form just about 20% of the revenues of the Indian pharma industry. As such, the penetration of the pharma industry in the rural markets is relatively lower compared to other industries such as two-wheelers, fast-moving consumer goods (FMCGs), gold consumption, etc. As a result, big drugmakers like Novartis, Ranbaxy Laboratories, Pfizer, Aventis Pharma and GSK Pharma are aiming to achieve the same kind of penetration in the hinterland markets. However, they seem to be facing a slew of challenges in these markets. One, health is still low on priority in villages; for every 25,000 people there is just one doctor. Certain estimates claim average per capital rural spending on medicines to be just Rs 100 per year. Additionally, there is a dearth of good healthcare infrastructure and stiff competition from small regional pharma players as well.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Stock markets open on a solid note". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.